Comprehensive Care for Mrs. Smith: Managing End-Stage Liver Disease

QUESTION

rs. Smith (pronouns she, her, hers) is a 56-year-old female living with end-stage liver disease (ESLD) admitted for treatment of severe jaundice, severe abdominal distension, and new onset of confusion; history positive for chronic alcohol use syndrome, hepatitis C, and 30 pack/year tobacco use; discharged from this hospital 2 weeks ago after treatment for ESLD and hepatic transplant evaluation; status of placement on transplant list pending transplant team final determination of client suitability for the procedure.​

ANSWER

Comprehensive Care for Mrs. Smith: Managing End-Stage Liver Disease

Introduction

Mrs. Smith, a 56-year-old female with a history of end-stage liver disease (ESLD), presents a complex and challenging case that demands a multidisciplinary approach to provide the best care possible. This essay explores the comprehensive care required for Mrs. Smith, addressing her medical history, risk factors, and potential interventions to manage ESLD and improve her overall health.

Comprehensive Care for Mrs. Smith: Managing End-Stage Liver Disease

Medical History and Risk Factors

Chronic Alcohol Use Syndrome: Mrs. Smith’s history of chronic alcohol use is a significant risk factor for the development of ESLD. This emphasizes the importance of addressing substance use disorders as part of her care plan. A multidisciplinary team, including addiction specialists and counselors, should be involved in providing addiction treatment, support, and relapse prevention strategies.

Hepatitis C: Hepatitis C is a known cause of liver damage and ESLD. The medical team should assess the extent of liver damage caused by hepatitis C, determine the need for antiviral therapy, and monitor the viral load and liver function throughout the treatment.

Tobacco Use: Mrs. Smith’s tobacco use, with a 30-pack-year history, poses an additional health risk. Smoking cessation interventions should be initiated, as continued tobacco use may exacerbate her ESLD and increase the risk of post-transplant complications.

Medical Management and Interventions

Hepatic Transplant Evaluation: Mrs. Smith’s pending placement on the transplant list indicates the potential for a life-saving procedure. Close collaboration with the transplant team is essential to assess her suitability and candidacy for transplantation. The medical team should ensure all necessary evaluations, including psychosocial assessments, are completed.

Symptom Management: Mrs. Smith’s severe jaundice, abdominal distension, and confusion require immediate symptom management. Jaundice may be addressed with dietary modifications, medication, or potential interventions like paracentesis for abdominal distension. Confusion may be related to hepatic encephalopathy, necessitating medication adjustments and dietary changes.

Nutritional Support: Nutritional interventions are crucial in managing ESLD. A registered dietitian should create a personalized nutritional plan to address malnutrition and optimize liver function. This may include protein management, sodium restriction, and vitamin supplementation.

Mental Health and Psychosocial Support: Given Mrs. Smith’s history of alcohol use and the potential stress associated with ESLD and transplantation, addressing her mental health is critical. Access to psychological counseling and support groups can help her cope with these challenges.

Medication Management: Medication reconciliation and management are essential to prevent drug-induced liver injury. Medications metabolized by the liver must be carefully monitored, and alternative options should be explored where necessary.

Transplantation Education: Mrs. Smith and her family should receive comprehensive education about the transplant process, including post-transplant care, immunosuppression, and the potential risks and benefits. Informed decision-making is vital.

Patient and Family Support

Caregiver Support: Mrs. Smith’s family plays a significant role in her care. Ensuring they have access to caregiver support programs can help them navigate the complexities of ESLD and transplantation.

Advance Care Planning: Involving Mrs. Smith in advance care planning discussions, including her end-of-life preferences and goals of care, is vital to ensure her wishes are respected.

Conclusion

Comprehensive care for Mrs. Smith, living with ESLD, involves addressing her medical history, risk factors, and potential interventions. Collaboration among healthcare professionals, including addiction specialists, transplant teams, dietitians, and mental health providers, is crucial to improving her overall health and managing the complexities associated with ESLD. Additionally, patient and family support, along with advance care planning, are essential components of her care plan to ensure her well-being and informed decision-making throughout her medical journey.